Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists

Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists

US Patent 6762186 · Granted Jul 13, 2004

Estimated economic value: $81,915,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PAPD5 inhibitors and methods of use thereof2025
Substituted heterocycles as aldehyde dehydrogenase inhibitors2024
Small molecule inhibitors of NF-kB inducing kinase2023
Small molecule inhibitors of NF-κB inducing kinase2022
Compounds and their use for reducing uric acid levels2021
Compounds and their use for reducing uric acid levels2021
Pyridinyl pyrazoles as modulators of RORγT2021
Compounds and their use for reducing uric acid levels2021
Phenyl substituted pyrazoles as modulators of RORγt2021
Compounds and their use for reducing uric acid levels2020
Compounds and their use for reducing uric acid levels2020
Aminopyrazine compounds with A2A antagonist properties2020